Literature DB >> 1675664

Focal stimulation of the mossy fibers releases endogenous dynorphins that bind kappa 1-opioid receptors in guinea pig hippocampus.

J J Wagner1, C J Evans, C Chavkin.   

Abstract

Physiological release of endogenous opioids in guinea pig hippocampal slices was detected in an in vitro competition binding assay using [3H]U69,593, a kappa 1-selective radioligand. Veratridine-induced opioid release caused a decrease in [3H]U69,593 binding that was blocked by either tetrodotoxin addition or the removal of calcium from the incubation buffer. Focal electrical stimulation of opioid peptide-containing afferent pathways resulted in a decrease in [3H]U69,593 binding, whereas stimulation of a major afferent lacking endogenous opioid immunoreactivity had no effect. The addition of 6-cyano-7-nitroquinoxaline-2,3-dione blocked the reduction in [3H]U69,593 binding caused by perforant path stimulation, but not the reduction caused by mossy fiber stimulation, suggesting that the primary source of endogenous kappa ligands was likely to be the dentate granule cells. Antisera against dynorphin A(1-8) or dynorphin B peptides inhibited the effects of mossy fiber stimulation in the [3H]U69,593 displacement assay. Antisera against other prodynorphin- and proenkephalin-derived opioid peptides had no effect. As shown by receptor autoradiography, the distribution of kappa 1 binding sites was limited to the molecular layer of the dentate gyrus and the presubiculum region of temporal hippocampal slices. These results indicate that prodynorphin-derived opioids released under physiological conditions from the mossy fibers act at kappa 1 receptors in the guinea pig dentate gyrus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675664     DOI: 10.1111/j.1471-4159.1991.tb02132.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Opioid modulation of recurrent excitation in the hippocampal dentate gyrus.

Authors:  G W Terman; C T Drake; M L Simmons; T A Milner; C Chavkin
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

2.  Synaptic localization of kappa opioid receptors in guinea pig neostriatum.

Authors:  C Jomary; J E Gairin; A Beaudet
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

3.  A presynaptic locus for long-term potentiation of elementary synaptic transmission at mossy fiber synapses in culture.

Authors:  J C López-García; O Arancio; E R Kandel; D Baranes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

4.  Characterizing the site and mode of action of dynorphin at hippocampal mossy fiber synapses in the guinea pig.

Authors:  P E Castillo; P A Salin; M G Weisskopf; R A Nicoll
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

5.  Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus.

Authors:  J J Wagner; G W Terman; C Chavkin
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

6.  Activation of κ opioid receptors increases intrinsic excitability of dentate gyrus granule cells.

Authors:  Carmel M McDermott; Laura A Schrader
Journal:  J Physiol       Date:  2011-05-23       Impact factor: 5.182

7.  Depolarization-induced suppression of spontaneous release in the avian midbrain.

Authors:  Mario Alexander Penzo; José Luis Peña
Journal:  J Neurosci       Date:  2011-03-09       Impact factor: 6.167

Review 8.  Dynorphin--still an extraordinarily potent opioid peptide.

Authors:  Charles Chavkin
Journal:  Mol Pharmacol       Date:  2012-11-14       Impact factor: 4.436

Review 9.  Activity-dependent regulation of synapses by retrograde messengers.

Authors:  Wade G Regehr; Megan R Carey; Aaron R Best
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

Review 10.  Dynorphin and its role in alcohol use disorder.

Authors:  Anushree N Karkhanis; Ream Al-Hasani
Journal:  Brain Res       Date:  2020-02-28       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.